lutetium Lu 177-DOTA-edotreotide

Definition / meaning of lutetium Lu 177-DOTA-edotreotide

A radioconjugate consisting of the octreotide derivative edotreotide (Tyr3-octreotide or TOC) labeled with lutetium Lu 177 with receptor ligand, beta-emitting radioisotope, and potential antineoplastic activities. Similar to the somatostatin analog octreotide, lutetium Lu 177-edotreotide binds to somatostatin receptors (SSTRs), especially type 2 receptors, present on the cell membranes of many types of neuroendocrine tumor cells. Upon binding and internalization, this radioconjugate specifically delivers a cytotoxic dose of beta radiation to SSTR-positive cells. Lutetium Lu 177-edotreotide is produced by substituting tyrosine for phenylalanine at the 3 position of the somatostatin analogue octreotide and chelating the substituted octreotide to Lu 177 via dodecanetetraacetic acid (DOTA).

Listed under:

Find More About 'lutetium Lu 177-DOTA-edotreotide'


The Web site of the National Cancer Institute (

Leave a Comment